Your session is about to expire
← Back to Search
Corticosteroid
Amino Acid Group for Atopic Dermatitis
Phase 3
Waitlist Available
Led By Alexandra Kimball, MD
Research Sponsored by NeoStrata Company, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks
Awards & highlights
Study Summary
The purpose of this study is to compare the effects of an amino acid moisturizing cream and desonide cream in reducing skin symptoms associated with AD/eczema in subjects with mild to moderate atopic dermatitis/eczema.
Eligible Conditions
- Atopic Dermatitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in skin effects of an amino acid moisturizing cream and desonide cream in reducing skin symptoms associated with AD/eczema in subjects with mild to moderate atopic dermatitis/eczema.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Amino Acid GroupExperimental Treatment1 Intervention
Group randomly receiving amino acid moisturizing cream as the treatment cream for 3 weeks. Fifteen (15) gram tubes are dispensed at the beginning of each week and will be applied twice daily, by the subject, during the 3 week treatment phase.
Group II: Desonide GroupActive Control1 Intervention
Group randomly receiving desonide cream as the treatment cream for 3 weeks. Fifteen (15) gram tubes are dispensed at the beginning of each week and will be applied twice daily, by the subject, during the 3 week treatment phase.
Find a Location
Who is running the clinical trial?
NeoStrata Company, Inc.Lead Sponsor
4 Previous Clinical Trials
125 Total Patients Enrolled
Massachusetts General HospitalOTHER
2,943 Previous Clinical Trials
13,200,947 Total Patients Enrolled
Alexandra Kimball, MDPrincipal InvestigatorMassachusetts General Hospital: Clinical Unit for Research Trials in Skin
Share this study with friends
Copy Link
Messenger